Markets
Nikkei 225
23,516.19
▲ +42.32 / +0.18%
SSE Composite
3,278.00
▼ -34.50 / -1.04%
Bovespa
101,259.75
▼ -657.98 / -0.65%
Straits Times
2,537.39
▲ +8.98 / +0.36%
BMV IPC
38,707.72
▲ +55.52 / +0.14%
Dow Jones
28,335.57
▼ -28.09 / -0.10%
DAX 30
12,645.75
▲ +102.69 / +0.82%
BSE SENSEX
40,685.50
▲ +127.01 / +0.31%
FTSE 100
5,860.28
▲ +74.63 / +1.29%
JSE Top 40
50,692.28
▲ +415.44 / +0.31%
Market News
- FTSE 100: The UK’s FTSE index closed up this past Friday 1.29%, showing signs of hope as Europe continues to be hit by a second wave of COVID-19.
- SSE Composite: In Asia, China’s SSE Composite closed down 1.04% this past Friday.
- Bovespa: As coronavirus cases continue to rise in Brazil, the state of the country’s BOVESPA index remains unsteady. This past Friday, it closed down at 0.65%.
Last Week’s Highlights
Russian Development of Nerve Agents
Recent investigations by Bellingcat have uncovered information about the development of nerve agents by Russian scientists. In fact, it appears that there are entire programs dedicated to this kind of drug development and perfection. Russian agents have historically used these kinds of drugs to do away with and poison enemies of the state.
Vaccine Doubts Set Aside, as Trials Begin Again
After several SARS-CoV-2 vaccine trials in the US were recently halted, the public around the world was left wondering what is to come. However, Johnson & Johnson and AstraZeneca have begun their vaccines’ trial runs once again. Trepidation that illnesses presented by several patients participating in these clinical trials were caused by the vaccine’s components have been put to rest, with both Big Pharma companies explaining that the illnesses were unrelated.
Coming Up This Week
Cases Keep Rising
Will there ever be a break, or will cases continue on and on in a peak and trough pattern? New record cases around the world, including Russia and the US, continue to overcome past records from months prior. The WHO announced recently that many countries are reaching unmanageable numbers of patients, overwhelming hospitals and clinics around the globe.
The US-China Relationship, History’s Perspective
The United States and China have had a historically complex relationship. The Trump presidency has only shown more clearly how the two superpowers tend to push each other’s buttons, and the pandemic has revealed this even more. In the latest pushback by Beijing, President Xi Jinping took a jab at the US, citing that bully behavior won’t lead to progress. Time will only tell who will make the next move in the countries’ ever-evolving political dance.
More Things to Sip On…
Ethiopia announces jail time for those who refuse to wear a protective mask amid the current pandemic.
Tesla is untouchable, right? After a recent recall in China, consumers aren’t so sure.
Phillipino General Antonio Parlade sends a threatening message to women of the Southeast Asian island country.
Academy
5 Investment Tips To Become A Smart Investor
“Why don’t you invest? Or why do your friends not invest? Many millennials report mistrust of the market, lack of know-how, insufficient funds, and student debt as barriers that prevent them from investing.”
6 Steps to set your Personal Financial Goals
“No matter what stage of life you currently find yourself in, we’re pretty sure that you’ve given some thought about both your short- and long-term personal financial goals.”
20 Side Hustle Ideas to Boost Your Income
“A side gig, moonlighting, or, as the kids call it these days, a side hustle is an excellent way to diversify your income, make a hobby profitable, and even build your confidence.”
“During recession greed dies, frugality survives.”
– Amit Kalantri –
Disclaimer
Visit our Disclosures section for additional information. All market information provided was collected in the afternoon of October 23, 2020. The purpose of NewsFlight is to summarize and make accessible information on a variety of topics within the world of investing and personal finance, and thus cannot be considered formal research or reports. All sources utilized to compile the NewsFlight newsletter are considered trustworthy by the FlexInvest team. FlexInvest is not affiliated with and does not receive remuneration from the news sources used to compile NewsFlight. As well, any images or logos incorporated into the NewsFlight newsletter are not necessarily property of FlexInvest and may solely be included to provide context for the news covered. NewsFlight should not be taken as advice to sell or buy securities or to make any investment. When investing in securities or other financial products, there is always the potential to lose money or asset value. FlexInvest recommends that its users consider their investment objectives and risks before investing. Additionally, any projections or analysis made by authors of NewsFlight cannot be considered as a promise of future trends or returns. Opinions expressed in News Flight are not representative of FlexInvest Inc.
